NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Implementation of Networked Continuous Glucose Monitoring With Telemetry Within the Intensive Care Unit (ICU-TeleCGM)

Not Yet RecruitingN/A

Sponsor: Imperial College Healthcare NHS Trust

Conditions: Type 1 Diabetes, Type 2 Diabetes Treated With Insulin, Hyperglycemia, Intensive Care (ICU), Continuous Glucose Monitoring

Interventions: Dexcom G7, ViewsEMR telemetry

Countries: United Kingdom

The aim of this observational study is to assess safety and implementation of continuous glucose monitors within the Intensive Care Unit. The Dexcom G7 is a continuous glucose monitoring system that shows blood glucose values in real-time and includes alarms if the glucose is very low or high.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Age \>18years inclusive
* Hyperglycaemia requiring insulin therapy (subcutaneous injection or intravenous insulin) during admission on ICU
* Admission to ICU within 48hours

Exclusion Criteria:

* Known significant allergy to tape/ adhesives
* Imminent death or anticipated length of stay \<24hours
* Women who are pregnant
* Imminent extracorporeal membrane oxygenation (ECMO)
* Requirement for therapeutic temperature control (i.e. cooling) post cardiac arrest

Locations (1)

London, United Kingdom